The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Lebrikizumab is approved for treating moderate-to-severe Atopic Dermatitis in adults and adolescents aged 12 years and older, weighing at least 40 kg, who require systemic therapy
It is important to note that liraglutide also upregulates these enzymes in the inguinal and cluneal adipose tissue and causes deposition of lower-body subcutaneous fat [132]
These results were not surprising based on how the two drugs work, Dr
Signs & Symptoms Fatigue, weakness Swelling (edema) in legs, face Decreased urine output (oliguria/anuria) or sometimes polyuria in early CKD Nausea, vomiting, anorexia Shortness of breath (due to fluid overload) Confusion (from uremia) High blood pressure Itchy skin (uremic pruritus) Complications Electrolyte imbalance ( potassium arrhythmias) Metabolic acidosis Anemia ( erythropoietin) Bone disease (due to calcium-phosphate imbalance, vitamin D activation) Cardiovascular disease Management AKI: Treat underlying cause (e.g., fluids for dehydration, relieve obstruction, stop nephrotoxic drugs)
When will a pill form of the drug be made available